13G INITIAL

Company

BRAINSTORM CELL THERAPEUTICS INC.

Filed

November 13, 2024

Accession Number

0001980840-24-000001

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →